May 31, 2010

Covidien to Acquire ev3

June 1, 2010—Covidien (Mansfield, MA) and ev3 Inc. (Plymouth, MN) announced that they have signed a definitive merger agreement under which Covidien will acquire all of the outstanding shares of ev3 for $22.50 per share in cash, for a total of $2.6 billion. The acquisition will enable Covidien to expand its presence in the vascular market with ev3's platform of peripheral vascular and neurovascular technologies, the companies stated.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

May 31, 2010

Covidien to Acquire ev3

Current Issue

Keep In Touch